Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Merck
Baxter
Medtronic

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Claims for Patent: 8,697,442

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 8,697,442
Title:Isolation of cells
Abstract: The invention relates to a method for isolating cells from a tissue sample. In preferred embodiments, chondrocytes are isolated from cartilage tissue in a shorter time than hitherto considered possible.
Inventor(s): Hendriks; Jeanine Anna Alphonse (Amerongen, NL), Adesida; Adetola Bamidele (Manchester, GB)
Assignee: Cellcotec B.V. (Bilthoven, NL)
Application Number:12/439,145
Patent Claims:1. A method to repair cartilage in a subject by implantation of chondrocytes comprising (a) subjecting a cartilage tissue sample from said subject to a single digestion enzyme or to more than one digestion enzyme sequentially or simultaneously, wherein the total period of time of exposure to the single digestion enzyme or to said more than one digestion enzymes is at least ten minutes and less than 2 hours to release said chondrocytes, (b) isolating the chondrocytes released in step (a) by separating the chondrocytes from the digestion enzyme or enzymes, thereby effectively ending the digestion process to obtain isolated chondrocytes, and directly implanting the chondrocytes into said subject; wherein said method employs step (a) as the only treatment of said sample with any digestion enzyme.

2. The method according to claim 1, wherein the tissue sample is subjected to said enzymatic digestion for a period of less than 1 hour.

3. The method according to claim 1, wherein the cartilage tissue is articular cartilage.

4. The method according to claim 1, wherein at least one digestion enzyme is selected from the group consisting of collagenases, pronases, dispases, trypsins, hyaluronidases, chondroitinases, elastases, and heparitinases.

5. The method according to claim 4, wherein at least one digestion enzyme is collagenase type II.

6. The method according to claim 1, wherein the isolated chondrocytes are harvested by filtration, washing, centrifuging, and/or magnetic bead extraction.

7. The method according to claim 1, wherein the tissue sample is pretreated to increase extracellular matrix permeability prior to subjecting it to the enzymatic digestion of step (a) by increasing repulsive forces between glycosaminoglycans present in the extracellular matrix or by contacting the tissue sample with an acid, a base, dimethyl sulfoxide, glycerol, or cations.

8. The method according to claim 1, wherein the tissue sample is subjected to said enzymatic digestion for a period of 30 minutes or less.

9. The method according to claim 1, wherein the tissue sample is subjected to said enzymatic digestion for a period of 10 minutes.

10. A method for preparing chondrocytes from a cartilage tissue sample for use in implantation to repair cartilage comprising (a) pretreating the tissue sample with an acid, a base, DMSO or glycerol, directly followed by subjecting the tissue sample to a single digestion enzyme or to more than one digestion enzyme sequentially or simultaneously, wherein the total period of time of exposure to the single digestion enzyme or to said more than one digestion enzymes is at least ten minutes and less than 2 hours to release said chondrocytes, and (b) isolating the chondrocytes released in step (a) by separating the chondrocytes from the digestion enzyme or enzymes, thereby effectively ending the digestion process to obtain isolated chondrocytes, and wherein said method employs step (a) as the only treatment of said sample with any digestion enzyme.

11. The method according to claim 10, wherein the tissue sample is subjected to said enzymatic digestion for a period of less than 1 hour.

12. The method according to claim 10, wherein the tissue sample is subjected to said enzymatic digestion for a period of 30 minutes or less.

13. The method according to claim 10, wherein the tissue sample is subjected to said enzymatic digestion for a period of 10 minutes.

14. The method according to claim 10, wherein the cartilage tissue is articular cartilage.

15. The method according to claim 10, wherein at least one digestion enzyme is selected from the group consisting of collagenases, pronases, dispases, trypsins, hyaluronidases, chondroitinases, elastases, and heparitinases.

16. The method according to claim 10, wherein at least one digestion enzyme is collagenase type II.

17. The method according to claim 10, wherein the isolated chondrocytes are harvested by filtration, washing, centrifuging, and/or magnetic bead extraction.

Summary for Patent:   Start Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
06076645Aug 31, 2006
PCT Information
PCT FiledAugust 31, 2007PCT Application Number:PCT/NL2007/050431
PCT Publication Date:March 06, 2008PCT Publication Number:WO2008/026929

Details for Patent 8,697,442

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Cellcotec B.V. (Bilthoven, NL) 2026-08-31 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,697,442

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Medtronic
Harvard Business School
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.